Health Opportunities and Promoters of Equitable Screening for Lung Cancer

Trial Title: Health Opportunities and Promoters of Equitable Screening for Lung Cancer

NCT ID: NCT05784922

Condition: Lung Cancer
Smoking Behaviors
Diagnosis

Conditions: Official terms:
Lung Neoplasms

Conditions: Keywords:
lung cancer screening
Hispanic outreach
educational intervention
digital health
smoking documentation
smoking history
health equity

Study type: Observational

Overall status: Active, not recruiting

Study design:

Time perspective: Prospective

Intervention:

Intervention type: Other
Intervention name: Educational Lung Cancer Screening (LCS) Video
Description: An educational video on lung cancer screening tailored to Hispanic current and former smokers.
Arm group label: Digital Outreach: Email
Arm group label: Digital Outreach: Patient Gateway
Arm group label: Digital Outreach: Text

Summary: The goal of this clinical trial is to promote lung cancer screening (LCS) uptake among Hispanic current and former smokers. The main questions it aims to answer are: - What barriers do current and former Hispanic smokers face in the identification and documentation of their smoking status? - How can digital delivery of an educational video promote LCS uptake among current and former Hispanic smokers? Participants will receive an educational video about lung cancer screening and complete brief, self-reported surveys afterwards.

Detailed description: Lung cancer remains the leading cause of cancer-specific mortality in the US, and Hispanics experience worse lung cancer outcomes and die at higher rates due to advanced stage at presentation. Lung cancer screening (LCS) can save many lives through early lung cancer detection among Hispanic current and former smokers. Still, without increasing efforts to improve smoking status disclosure and documentation and tailored interventions to promote LCS uptake among Hispanic current and former smokers, this underserved population will continue to demonstrate disparities in lung cancer survival. Based on prior research experience, Dr. Flores has adapted the NIMHD research framework by incorporating elements from Ford's evidence-based theoretical model to guide the following proposed study aims: 1) To elucidate barriers and facilitators to consistent identification and documentation of smoking status to promote LCS uptake among Hispanic current and former smokers; 2) To assess feasibility, acceptability, and reach of the digital delivery of an educational video to promote LCS uptake among Hispanic current and former smokers; 3) To explore the effect of the digital delivery of the educational video to increase interest, intent, and scheduling of LCS uptake among Hispanic current and former smokers. Impact: The successful completion of this research will serve as a foundation for developing novel interventions to overcome disparities and advance equity in lung cancer outcomes among Hispanics and other vulnerable populations.

Criteria for eligibility:

Study pop:
Investigators chose to restrict eligibility to adults aged 50-80 with no personal history of lung cancer to meet the United States Preventive Services Task Force Guidelines for lung cancer screening. As the primary aim of this study is to address the disparities in lung cancer screening rates and outcomes for Hispanic individuals, only Hispanic-identifying patients will be eligible for participation. Further grants stemming from this project will include community-based outreach efforts to extend the testing and dissemination of this intervention to other underrepresented groups.

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria: - Must be 50-80 years old - Are a current or former smoker (quit within 15 years, or a cumulative smoking status of > 20 pack-years) - Not currently enrolled in Lung Cancer Screening - Must speak English or Spanish Exclusion Criteria: - Has a clinical cognitive inability to provide informed consent for participation in the study or complete a brief survey - Currently diagnosed with lung cancer - Currently enrolled in lung cancer screening - Have participated in the focus groups discussions from Aim 1

Gender: All

Minimum age: 50 Years

Maximum age: 80 Years

Healthy volunteers: No

Locations:

Facility:
Name: Massachusetts General Hospital

Address:
City: Boston
Zip: 02114
Country: United States

Start date: February 3, 2023

Completion date: January 31, 2028

Lead sponsor:
Agency: Massachusetts General Hospital
Agency class: Other

Collaborator:
Agency: National Cancer Institute (NCI)
Agency class: NIH

Source: Massachusetts General Hospital

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05784922